Conventional Sacroiliac Joint Injection Versus Pulsed Radiofrequency in SIJ Pain
Not yet recruitingNot applicableNCT07709689
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Therapeutic options for SIJ pain include intra-articular corticosteroid injections, which provide symptomatic relief but typically require repeated administration due to variable and short-lived efficacy. More recently, pulsed radiofrequency (PRF) has been investigated for joint pain management through intra-articular electrode placement and stimulation. However, its effectiveness in treating SIJ pain remains insufficiently studied and warrants further exploration.
Study details
- Official title
- Unlocking Sacroiliac Joint Pain: A Comparative Study of Pulsed Radiofrequency and Conventional Technique
- Conditions
- Chronic Pain
- Sacroiliitis
- Interventions
- Procedure: Conventional injection
- Procedure: Pulsed radiofrequency (PRF)
- Sponsor
- National Cancer Institute, Egypt
- Start date
- 2026-07-12
- Primary completion
- 2027-08
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion criteria * Sacroiliac Joint (SIJ) Pain * Diagnostic Block Response: Demonstrated a pain reduction of at least 50% following a diagnostic intra- articular SIJ block. * Failure of Medical Management * Chronic Pain Duration: Presence of chronic pain for a minimum duration of 6 months. * Pain Intensity: A pain intensity score greater than 5 on a 10-point Numeric Rating Scale (NRS), where 0 represents no pain and 10 represents the worst imaginable pain. * Age: Aged between 18 and 65 years. * Body Mass Index (BMI): A BMI within the range of 20 kg/m² to 35 kg/m². Exclusion Criteria: * Patient refusal. * Local infection at the puncture site. * Coagulopathies with platelets count below 50,000 or an INR\>1.6. * Unstable cardiovascular disease and Poor general condition and severe respiratory distress. * History of psychiatric and cognitive disorders or opioid addiction. * Patients are allergic to medication used. * Previous surgery to the affected site. * Rheumatological disease such as rheumatoid arthtritis or ankylsoing spondyolitis.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07709689